Pharmaceutical company
Nicholas Pharmaceuticals
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
11products
4generics
1therapeutic areas
11current prices
Portfolio intelligence
Therapeutic mix
Third-generation cephalosporins 6Unclassified 5
Company portfolio
11 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Cefzect | Ceftriaxone | 500 mg | IM injection | 1's | 094295 | PKR 318.21 |
| Cefzect | Ceftriaxone | 2 g | IV injection | 1's | 094293 | PKR 842.33 |
| Cefzect | Ceftriaxone | 250 mg | Injection | 1's | 094290 | PKR 189.06 |
| Cefzect | Ceftriaxone | 1 g | Injection | 1's | 094296 | PKR 600.87 |
| Cefzect | Ceftriaxone | 250 mg | IM injection | 1's | 094294 | PKR 189.06 |
| Cefzect | Ceftriaxone | 500 mg | Injection | 1's | 094291 | PKR 318.21 |
| Naftoxime | Cefotaxime | 2 g | Injection | 1's | 094302 | PKR 436.15 |
| Naftoxime | Cefotaxime | 1 g | Injection | 1's | 094303 | PKR 272.42 |
| Nezdime | Ceftazidime | 250 mg | Injection | 1's | 094299 | PKR 152.13 |
| Nezdime | Ceftazidime | 1 g | Injection | 1's | 094298 | PKR 434.64 |
| Noopem | Meropenem | 1 g | IV injection | 1's | 094313 | PKR 3,743.73 |